| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.096 | 0.02 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |